Clinical Trial Update: A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 long-term study of YM060 in female patients with diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea-predominant Irritable Bowel Syndrome

Drugs mentioned

• YM060

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Diarrhea-predominant Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED